Other
Closed-loop insulin delivery
Closed-loop insulin delivery is an intervention with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
3
75%
Ph not_applicable
1
25%
Phase Distribution
0
Early Stage
3
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
3(75.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 23 (75.0%)
N/A1 (25.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_2
Closed Loop Glucose Control in Intensive Care Unit
NCT01440842
completednot_applicable
Achieving Normal Glucose In Hospital Settings
NCT01359241
completedphase_2
Closing the Loop for 36 Hours in Adolescents With Type 1 Diabetes: Evaluation of Reduced Meal Bolusing
NCT01629251
completedphase_2
Closing the Loop for 36 Hours in Adolescents With Type 1 Diabetes
NCT01074801
Clinical Trials (4)
Showing 4 of 4 trials
NCT01440842Phase 2
Closed Loop Glucose Control in Intensive Care Unit
NCT01359241Not Applicable
Achieving Normal Glucose In Hospital Settings
NCT01629251Phase 2
Closing the Loop for 36 Hours in Adolescents With Type 1 Diabetes: Evaluation of Reduced Meal Bolusing
NCT01074801Phase 2
Closing the Loop for 36 Hours in Adolescents With Type 1 Diabetes
All 4 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 4